CenTrial Logo

COPD with Chronic Bronchitis: Exploring NAC as a Potential Treatment Option


Clinical trial finds that NAC treatment for COPD is not beneficial

Chronic Obstructive Pulmonary Disease (COPD) is a severe respiratory condition affecting the lungs. It is commonly associated with chronic bronchitis, a condition characterized by inflammation and narrowing of the airways, leading to excessive mucus production and a persistent cough. People with this condition often experience persistent coughing, shortness of breath, and increased mucus production. COPD with bronchitis is usually caused by smoking or exposure to harmful pollutants. It's a progressive disease that worsens over time, leading to reduced lung function and decreased quality of life. Quitting smoking, avoiding irritants, and following a doctor's treatment plan can help manage COPD with bronchitis.

In the search for effective treatment options, N-acetylcysteine (NAC) has been considered a potential therapeutic choice for COPD patients with chronic bronchitis. NAC is an antioxidant and mucolytic agent that helps break down mucus, making it easier to clear the airways. It is commonly used to manage chronic bronchitis symptoms and to improve lung function.

Clinical Trial

A randomized, double-blind, placebo-controlled trial was conducted to assess the clinical efficacy of high-dose oral NAC for COPD patients with concurrent chronic bronchitis. The study enrolled 143 participants initially, but only 100 patients were ultimately included in the research. These patients were randomly assigned to receive either 900 mg of NAC twice daily or a matching placebo for three months.

The study's primary endpoint was the evaluation of respiratory health status using the St. George's Respiratory Questionnaire (SGQR). The SGQR is a validated tool that assesses various aspects of respiratory health and quality of life, including symptoms, activity limitations, and social and psychological well-being impacts.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me


After the three-month treatment period, there were no significant differences in SGQR scores between the patients who received NAC and the placebo group. Additionally, the two groups had no significant differences in secondary endpoints after treatment.

The study's findings suggest that high-dose oral NAC does not provide marked clinical benefits for COPD patients with concurrent chronic bronchitis. While NAC is known for its potential therapeutic effects in managing chronic bronchitis symptoms, it appears that at this high dosage and in this specific patient population, it may not lead to significant improvements in respiratory health and quality of life.

It is important to note that medical research is an ongoing process, and results from one study may not be conclusive. Further investigations are needed to explore alternative treatment options and uncover subsets of COPD patients with chronic bronchitis who may benefit from NAC or other interventions.


Overall, COPD and chronic bronchitis remain challenging respiratory conditions that require comprehensive management approaches, including smoking cessation, pulmonary rehabilitation, and the appropriate use of medications based on individual patient needs and characteristics.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Without participants there can be no clinical trials.
Without clinical trials there will be no new treatments.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.